WebMar 21, 2014 · DESTINY II was a multicenter randomized controlled trial (RCT) of decompressive hemicraniectomy surgery vs. medical care for patients age >60 with large hemispheric ischemic strokes with brain … WebJan 14, 2016 · All three controlled trials had an age limit of 60 years for inclusion. More recently the DESTINY II trial investigated how hemicraniectomy affects patients older than 60 years of age. ... A recent trial, DESTINY II, focusing on this elderly population of stroke-afflicted patients, found better outcomes: mRS of 0–4 present in 38% in the ...
Evidence review for decompressive hemicraniectomy
WebMar 24, 2014 · This occurred in 38% of the hemicraniectomy group compared with 18% of the control group (odds ratio, 2.91; 95% confidence interval, 1.06 - 7.49; P = .04). … WebFeb 9, 2007 · 93 patients were included in the pooled analysis. More patients in the decompressive-surgery group than in the control group had an mRS≤4 (75% vs 24%; pooled absolute risk reduction 51% [95% CI 34–69]), an mRS≤3 (43% vs 21%; 23% [5–41]), and survived (78% vs 29%; 50% [33–67]), indicating numbers needed to treat of two for … ead.puc rio
DESTINY II: DEcompressive Surgery for the Treatment of
WebMar 24, 2024 · In a more recent prospective randomized clinical trial, Decompressive Surgery for Treatment of Malignant Infarction of Middle Cerebral Artery-II (DESTINY II trial) published in 2014, the efficacy of a decompressive hemicraniectomy within 48 h after stroke onset was investigated for elderly patients aged >60 years . In this trial, while … WebDec 19, 2024 · The initial three randomised controlled trials (DECIMAL , HAMLET and DESTINY ) considered individually or with pooled patient data analysis demonstrated that hemicraniectomy was superior to medical management alone in both survival and functional outcome measured using the modified Rankin score (mRS) where good … WebIn this trial, hemicraniectomy was associated with a statistically significant reduction of mortality from 59% to 22% (P 0.05). At the one-year follow-up assessment, 24% of the surviving surgical patients had a mRS of 5; 44% had a mRS of 4; 28% had a mRS of 3; and 4% had a mRS of 2. ... While DECIMAL and DESTINY trials demonstrated that the ... eads9584